For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)

Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.

Brexpiprazole (Rexulti): Uses, Side Effects, Warnings & More - GoodRx

For Alzheimer's Agitation, Promising News from Rexulti

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

REXULTI® (brexpiprazole) Agitation associated with dementia due

First FDA Approved Medication for Agitation Associated with

Antipsychotic Shows Benefit for Alzheimer's Agitation

Schizophrenia drug promising for Alzheimer's agitation - Seasons

Decision on Brexpiprazole for Alzheimer's Agitation Due in May

Why REXULTI® (brexpiprazole) agitation that may happen with

Dementia: FDA fast-tracks approval for antipsychotic drug Rexulti

SLU Researcher Finds Help for Alzheimer's-Associated Agitation